A new peer-reviewed study published in The Journal of Maternal-Fetal & Neonatal Medicine has evaluated the feasibility and acceptability of the SurePulse VS wireless heart rate monitoring device in preterm infants across a range of neonatal clinical settings.
The prospective multicentre observational study was conducted at two UK tertiary neonatal units: Norfolk and Norwich University Hospitals NHS Foundation Trust and Ashford and St Peter’s Hospitals NHS Foundation Trust. Researchers evaluated SurePulse VS in preterm infants at birth and during postnatal care, including in the delivery room, operating theatre and neonatal intensive care unit (NICU).
Clinical staff reported high levels of feasibility and acceptability when using SurePulse VS.
In the 51 infants included in the final analysis, 88% of deployments were rated “Easy” or “Very Easy” for cap fitting. Where infants also required continuous positive airway pressure (CPAP) or nasal high-flow respiratory support, 100% of staff reported that this could be integrated “Easily” or “Very Easily” with the SurePulse VS cap.
Heart rate visibility was reported as available for “All” or “Most” of the monitoring period in 82% of cases, while 69% reported heart rate acquisition within 60 seconds. Downloaded device data provided additional exploratory operational measures that broadly aligned with staff assessments.
The study also explored the use of wireless heart rate monitoring during early parent-infant contact. SurePulse VS was used while babies had their first cuddles with parents following birth and during skin-to-skin and Kangaroo Care in the NICU.
The researchers highlight the potential advantages of wireless monitoring in these settings, where conventional monitoring equipment can present practical challenges. They conclude that a cap-mounted wireless sensor is a feasible approach to heart rate monitoring both at birth and during neonatal intensive care alongside routine stabilisation.
The findings add to the growing clinical evidence supporting the use of SurePulse VS across the neonatal journey. Previous studies have evaluated the technology in stable late-preterm and term infants, while this study extends evaluation to preterm infants across delivery room, operating theatre and intensive care settings.
The authors conclude that SurePulse VS demonstrated a good level of feasibility and acceptability among neonatal staff, while also identifying the importance of training and workflow integration when introducing new monitoring technologies into routine neonatal care. They note that further studies are required to evaluate device performance and its potential role in routine clinical practice.
Reference